Acrylamide in Namkeen: What's Actually Proven vs. What Isn't

Recent tests have revealed that popular Indian snack brands contain elevated acrylamide levels compared to EU reference benchmarks. This is particularly concerning for India, where namkeen snacks are a staple in many households. With over 50% of the Indian population consuming these snacks regularly, the topic deserves careful attention. The lack of mandatory disclosure under current FSSAI labelling rules — India has no specific safety limit for acrylamide in food, unlike the EU's reference benchmark levels — means consumers currently have no way to know an individual product's acrylamide level from the label.

Acrylamide is classified by IARC as a Group 2A "probable human carcinogen" — a classification based primarily on strong evidence from animal studies, at doses far higher than typical human dietary exposure. The EU has set reference benchmark levels (not legal limits) for acrylamide in different food categories to guide manufacturers toward lower-acrylamide processing methods. India has no equivalent numeric standard specific to acrylamide in fried snacks, which is itself the main regulatory gap worth highlighting.

It's important to represent this honestly: while animal studies at very high doses (typically 1,000 to 100,000 times higher than normal human dietary exposure) have shown acrylamide causes cancer in rodents, the US National Cancer Institute's own review of human epidemiological studies has found no consistent evidence that dietary acrylamide intake increases cancer risk in humans at the levels people typically consume. This doesn't mean acrylamide is risk-free — the animal evidence and its plausible biological mechanism (DNA damage, per IARC) are real reasons for caution — but it does mean claims of a confirmed human cancer link overstate the current evidence. The honest position is: probable risk based on mechanism and animal data, with human epidemiological evidence still inconclusive.

Acrylamide forms naturally when starchy foods (potato, besan, wheat-based snacks) are fried or baked above roughly 120°C, through a reaction between the amino acid asparagine and natural sugars — the same reaction responsible for browning and flavour development, which is why acrylamide can't simply be "removed" without changing how a fried snack tastes and looks. A specific, practical concern in India's namkeen industry is reused frying oil: repeatedly reheating the same oil for cost-saving reasons has been flagged as a factor that can increase acrylamide formation, alongside longer frying times and higher temperatures used to achieve a crisper texture in some snack categories.

For home-fried snacks, a few adjustments meaningfully reduce acrylamide formation: fry at lower temperatures for longer rather than very high heat for a short time; avoid over-browning — aim for a golden colour rather than dark brown or blackened edges; soak starchy items like potato in water before frying to reduce surface sugar content; and avoid reusing frying oil multiple times, since repeated heating both degrades oil quality and appears to increase acrylamide formation in subsequent batches.

Children and individuals with a family history of cancer may reasonably choose to be more cautious, given the precautionary classification and biological plausibility, even though direct human epidemiological evidence remains inconclusive. In India, where namkeen snacks are a common part of the diet, exposure frequency is high simply due to how often these snacks are eaten. According to the Indian Council of Medical Research, the incidence of cancer in India is increasing, with over 1.4 million new cases reported in 2020 — a broader context for why minimising any plausible carcinogen exposure is a reasonable precaution, independent of acrylamide's specific, still-developing evidence base.

IARC's classification system is frequently misunderstood in consumer coverage: Group 2A means "probably carcinogenic to humans," a category based on the strength and consistency of available evidence, not the magnitude of risk at typical exposure levels — a common source of confusion, since the classification says nothing about how much a substance would need to be consumed to matter practically. Group 2A sits below Group 1 ("carcinogenic to humans," reserved for substances with strong human evidence, like tobacco or processed meat) and reflects primarily animal and mechanistic evidence with limited or inconsistent human data — precisely the situation described for acrylamide in this guide. This distinction matters because a Group 2A classification is often reported in headlines without this context, making a substance sound more definitively dangerous to humans than the underlying evidence currently supports.

Namkeen and fried snacks are a significant acrylamide source in an Indian diet, but they aren't unique — acrylamide forms in any starchy food browned through high-heat cooking, meaning roasted or toasted bread, roasted coffee, and even some baked goods contribute to overall dietary exposure alongside fried snacks. This broader context is useful for calibrating how much individual concern namkeen specifically deserves: reducing namkeen consumption addresses one significant contributor to total acrylamide exposure, but eliminating it alone doesn't eliminate dietary acrylamide exposure entirely, since the same browning reaction occurs across a wide range of commonly eaten cooked foods. This is consistent with how food safety agencies internationally have approached acrylamide — as a general cooking-method concern across many food categories, rather than a single-product issue.

The EU's acrylamide reference benchmark levels, introduced in 2017, function as guidance values manufacturers are expected to work toward through processing adjustments rather than legally enforced maximum limits with penalties attached — even in the EU, acrylamide regulation takes a softer, guidance-based form rather than a hard legal cap, reflecting how the science remains genuinely unsettled even among regulators taking a precautionary stance. India's absence of an equivalent numeric standard reflects both this general regulatory uncertainty and FSSAI's typical pattern of prioritising numeric standards for substances with more settled human evidence first. This isn't a defence of the regulatory gap — a benchmark system similar to the EU's would give Indian manufacturers a concrete target and consumers more information than currently exists — but it explains why the absence of an Indian standard doesn't necessarily mean Indian regulators consider the substance safe by comparison; it more likely reflects where acrylamide sits in FSSAI's broader regulatory priority queue.

Given the genuine uncertainty in human evidence but plausible biological mechanism and animal data, the most defensible response is moderate precaution rather than either dismissal or alarm: treating namkeen and other deep-fried snacks as an occasional food rather than a daily staple, favouring home preparation using the temperature and reuse guidance covered earlier when possible, and not singling out acrylamide as uniquely urgent compared to the other, better-established concerns with fried packaged snacks generally (excess sodium, refined carbohydrate, trans fat in some products). This proportionate framing — genuine caution without overstating settled human risk — is the position this guide has tried to model throughout, and it's a more useful stance than either ignoring the IARC classification entirely or treating it as equivalent to a confirmed human carcinogen finding.

Independent laboratory testing of Indian namkeen and fried snack brands has periodically found acrylamide levels exceeding the EU's reference benchmark values for comparable food categories, which is the basis for the concern this guide addresses — but it's worth being precise that exceeding a guidance benchmark is different from exceeding a legal safety limit, since as covered above the EU benchmarks themselves function as processing-improvement targets rather than hard safety thresholds. This testing gap is genuinely useful information for a consumer trying to make an informed choice, but it should be read as "this product's acrylamide level is higher than what EU manufacturers are guided toward achieving," not as "this product has been proven to cause cancer," a distinction that matters for accurately weighing the actual risk being described.

AaharIQ is a powerful tool that helps you make informed food choices. By scanning the label of your favorite snack, AaharIQ's AI-powered algorithm can flag products more likely to be high in acrylamide-forming processing methods and provide a personalized safety verdict based on your health profile. With AaharIQ, you can take control of your health with an accurate, evidence-based view rather than an overstated one. Visit aahariq.com to start scanning and stay safe today.

Does this mean namkeen is safe to eat regularly? It means the human cancer-risk evidence is less settled than some coverage suggests, not that acrylamide should be ignored entirely — moderate, occasional consumption rather than daily reliance remains the reasonable position given the combination of animal evidence and inconclusive human data. Can home-cooked namkeen be acrylamide-free? Not entirely, since acrylamide forms through browning regardless of who does the frying, but the temperature, timing, and oil-reuse adjustments covered above meaningfully reduce formation compared to commercial processing optimised for shelf life and crispness rather than minimising acrylamide. Is baked namkeen safer than fried? Generally yes to a degree — baking at lower sustained temperatures than deep frying tends to produce less acrylamide, though baked snacks aren't automatically acrylamide-free if baked at high heat for extended periods. Should I be more worried about acrylamide than sodium or trans fat in the same snacks? Based on current evidence, no — the sodium and trans fat content of many fried Indian snacks has considerably stronger, more consistent human evidence behind their health risks than acrylamide currently does.